KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) EBT Margin (2016 - 2025)

Historic EBT Margin for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 4.53%.

  • AbbVie's EBT Margin fell 98900.0% to 4.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.78%, marking a year-over-year decrease of 101800.0%. This contributed to the annual value of 6.6% for FY2024, which is 49100.0% down from last year.
  • According to the latest figures from Q3 2025, AbbVie's EBT Margin is 4.53%, which was down 98900.0% from 10.08% recorded in Q2 2025.
  • In the past 5 years, AbbVie's EBT Margin ranged from a high of 36.41% in Q1 2022 and a low of 15.02% during Q4 2024
  • Moreover, its 5-year median value for EBT Margin was 14.26% (2024), whereas its average is 15.11%.
  • As far as peak fluctuations go, AbbVie's EBT Margin skyrocketed by 395700bps in 2021, and later tumbled by -325200bps in 2023.
  • Over the past 5 years, AbbVie's EBT Margin (Quarter) stood at 28.69% in 2021, then plummeted by -32bps to 19.61% in 2022, then tumbled by -57bps to 8.47% in 2023, then plummeted by -277bps to 15.02% in 2024, then soared by 130bps to 4.53% in 2025.
  • Its EBT Margin stands at 4.53% for Q3 2025, versus 10.08% for Q2 2025 and 12.45% for Q1 2025.